Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

doi:10.1084/jem.167.3.1211

This Article

Full Text (PDF)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Tracey, K. J.

Articles by Cerami, A.

Search for Related Content

PubMed

PubMed Citation

Articles by Tracey, K. J.

Articles by Cerami, A.

Pubmed/NCBI databases

Medline Plus Health Information
Substance via MeSH
Anemia

Social Bookmarking

What's this?

ARTICLES

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

KJ Tracey, H Wei, KR Manogue, Y Fong, DG Hesse, HT Nguyen, GC Kuo, B Beutler, RS Cotran and A Cerami
Laboratory of Surgical Metabolism, New York Hospital-Cornell University Medical Center, New York, New York 10021.

Cachexia is a potentially lethal syndrome of unknown etiology characterized by anorexia, weight loss, and protein wasting that frequently complicates the treatment of chronic inflammation and cancer. Cachectin/TNF was isolated during the search for a humoral mediator of cachexia and found to stimulate the breakdown of energy stores from adipocytes and myocytes in vitro, but the chronic effects of the monokine in vivo are not known. Sublethal doses of recombinant human cachectin administered twice daily for 7-10 d caused cachexia in rats, as evidenced by reduced food intake, weight loss, and depletion of whole-body lipid and protein stores. Significant anemia is also observed and found to be the result of decreased red blood cell mass, not expanded plasma volume. Leukocytosis and histopathological evidence of tissue injury and inflammation are observed in several organs, including omentum, liver, spleen, and heart. These data suggests that the exposure of the normal host to cachectin is capable of inducing a pathophysiological syndrome of cachexia, anemia, and inflammation similar to that observed during inflammatory states or malignancy.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Sethu, S., Mendez-Corao, G., Melendez, A. J. (2008). Phospholipase D1 Plays a Key Role in TNF-{alpha} Signaling. J. Immunol. 180: 6027-6034 [Abstract] [Full Text]
Guruvayoorappan, C., Kuttan, G. (2007). Effect of Amentoflavone on the Inhibition of Pulmonary Metastasis Induced by B16F-10 Melanoma Cells in C57BL/6 Mice. Integr Cancer Ther 6: 185-197 [Abstract]
Aronson, D., Suleiman, M., Agmon, Y., Suleiman, A., Blich, M., Kapeliovich, M., Beyar, R., Markiewicz, W., Hammerman, H. (2007). Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J 28: 1289-1296 [Abstract] [Full Text]
Dogra, C., Changotra, H., Wedhas, N., Qin, X., Wergedal, J. E., Kumar, A. (2007). TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J. 21: 1857-1869 [Abstract] [Full Text]
Peterson, J. M., Feeback, K. D., Baas, J. H., Pizza, F. X. (2006). Tumor necrosis factor-{alpha} promotes the accumulation of neutrophils and macrophages in skeletal muscle. J. Appl. Physiol. 101: 1394-1399 [Abstract] [Full Text]
Ashwood, P., Wills, S., Van de Water, J. (2006). The immune response in autism: a new frontier for autism research. J. Leukoc. Biol. 80: 1-15 [Abstract] [Full Text]
Fairchild, K. D., Singh, I. S., Patel, S., Drysdale, B. E., Viscardi, R. M., Hester, L., Lazusky, H. M., Hasday, J. D. (2004). Hypothermia prolongs activation of NF-{kappa}B and augments generation of inflammatory cytokines. Am. J. Physiol. Cell Physiol. 287: C422-C431 [Abstract] [Full Text]
Heinonen, K. M., Nestel, F. P., Newell, E. W., Charette, G., Seemayer, T. A., Tremblay, M. L., Lapp, W. S. (2004). T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood 103: 3457-3464 [Abstract] [Full Text]
Giordani, L., Bruzzi, P., Lasalandra, C., Quaranta, M., Schittulli, F., Della Ragione, F., Iolascon, A. (2003). Association of Breast Cancer and Polymorphisms of Interleukin-10 and Tumor Necrosis Factor-{alpha} Genes. Clin. Chem. 49: 1664-1667 [Full Text]
Mann, D. L., Reid, M. B. (2003). Exercise training and skeletal muscle inflammation in chronic heart failure: feeling better about fatigue. J Am Coll Cardiol 42: 869-872 [Full Text]
Tracey, K. J. (2002). Lethal Weight Loss: The Focus Shifts to Signal Transduction. Sci Signal 2002: pe21-pe21 [Abstract] [Full Text]
Azuma, T, Suto, H, Ito, Y, Ohtani, M, Dojo, M, Kuriyama, M, Kato, T (2001). Gastric leptin and Helicobacter pylori infection. Gut 49: 324-329 [Abstract] [Full Text]
Misawa, S., Kuwabara, S., Mori, M., Kawaguchi, N., Yoshiyama, Y., Hattori, T. (2001). Serum levels of tumor necrosis factor-{{alpha}} in chronic inflammatory demyelinating polyneuropathy. Neurology 56: 666-669 [Abstract] [Full Text]
Encinas, J. A., Lees, M. B., Sobel, R. A., Symonowicz, C., Weiner, H. L., Seidman, C. E., Seidman, J. G., Kuchroo, V. K. (2001). Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis. Int Immunol 13: 257-264 [Abstract] [Full Text]
Chen, B.-C., Hsieh, S.-L., Lin, W.-W. (2001). Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages. J. Leukoc. Biol. 69: 280-288 [Abstract] [Full Text]
Melby, P. C., Chandrasekar, B., Zhao, W., Coe, J. E. (2001). The Hamster as a Model of Human Visceral Leishmaniasis: Progressive Disease and Impaired Generation of Nitric Oxide in the Face of a Prominent Th1-Like Cytokine Response. J. Immunol. 166: 1912-1920 [Abstract] [Full Text]
Teo, S. K., Evans, M. G., Brockman, M. J., Ehrhart, J., Morgan, J. M., Stirling, D. I., Thomas, S. D. (2001). Safety Profile of Thalidomide after 53 Weeks of Oral Administration in Beagle Dogs. Toxicol Sci 59: 160-168 [Abstract] [Full Text]
Greenberg, P. L., Gordeuk, V., Issaragrisil, S., Siritanaratkul, N., Fucharoen, S., Ribeiro, R. C. (2001). Major Hematologic Diseases in the Developing World-- New Aspects of Diagnosis and Management of Thalassemia, Malarial Anemia, and Acute Leukemia. ASH Education Book 2001: 479-498 [Abstract] [Full Text]
Teo, S, Evans, M, Ehrhart, J, Brockman, M, Allen, D, Morgan, M, Stirling, D, Thomas, S (2000). Lack of peripheral neuropathy in Beagle dogs after 53 weeks oral administration of thalidomide capsules. Hum Exp Toxicol 19: 615-622 [Abstract]
Selmaj, K. W (2000). Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system. Ann Rheum Dis 59: i94-102 [Full Text]
Li, Y.-P., Reid, M. B. (2000). NF-kappa B mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279: R1165-R1170 [Abstract] [Full Text]
TAKABATAKE, N., NAKAMURA, H., ABE, S., INOUE, S., HINO, T., SAITO, H., YUKI, H., KATO, S., TOMOIKE, H. (2000). The Relationship between Chronic Hypoxemia and Activation of the Tumor Necrosis Factor-alpha System in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 161: 1179-1184 [Abstract] [Full Text]
Croxford, J. L., Triantaphyllopoulos, K. A., Neve, R. M., Feldmann, M., Chernajovsky, Y., Baker, D. (2000). Gene Therapy for Chronic Relapsing Experimental Allergic Encephalomyelitis Using Cells Expressing a Novel Soluble p75 Dimeric TNF Receptor. J. Immunol. 164: 2776-2781 [Abstract] [Full Text]
Fox, D. A. (2000). Cytokine Blockade as a New Strategy to Treat Rheumatoid Arthritis: Inhibition of Tumor Necrosis Factor. Arch Intern Med 160: 437-444 [Abstract] [Full Text]
Islam, A. F. M. W., Moss, N. D., Dai, Y., Smith, M. S. R., Collins, A. M., Jackson, G. D. F. (2000). Lipopolysaccharide-Induced Biliary Factors Enhance Invasion of Salmonella enteritidis in a Rat Model. Infect. Immun. 68: 1-5 [Abstract] [Full Text]
van HEECKEREN, A. M., TSCHEIKUNA, J., WALENGA, R. W., KONSTAN, M. W., DAVIS, P. B., EROKWU, B., HAXHIU, M. A., FERKOL, T. W. (2000). Effect of Pseudomonas Infection on Weight Loss, Lung Mechanics, and Cytokines in Mice. Am. J. Respir. Crit. Care Med. 161: 271-279 [Abstract] [Full Text]
Yeh, S.-S., Schuster, M. W (1999). Geriatric cachexia: the role of cytokines. Am. J. Clin. Nutr. 70: 183-197 [Abstract] [Full Text]
Barber, M. D., Ross, J. A., Preston, T., Shenkin, A., Fearon, K. C. H. (1999). Fish Oil�Enriched Nutritional Supplement Attenuates Progression of the Acute-Phase Response in Weight-Losing Patients with Advanced Pancreatic Cancer. J. Nutr. 129: 1120-1125 [Abstract] [Full Text]
BALLINGER, A (1999). Divergency of leptin response in intestinal inflammation. Gut 44: 588-589 [Full Text]
TAKABATAKE, N., NAKAMURA, H., ABE, S., HINO, T., SAITO, H., YUKI, H., KATO, S., TOMOIKE, H. (1999). Circulating Leptin in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 159: 1215-1219 [Abstract] [Full Text]
Takahashi, N., Waelput, W., Guisez, Y. (1999). Leptin Is an Endogenous Protective Protein against the Toxicity Exerted by Tumor Necrosis Factor. J. Exp. Med. 189: 207-212 [Abstract] [Full Text]
Rosenbaum, S. E., Greenberg, A. S. (1998). The Short- and Long-Term Effects of Tumor Necrosis Factor-{alpha} and BRL 49653 on Peroxisome Proliferator-Activated Receptor (PPAR){gamma}2 Gene Expression and Other Adipocyte Genes. Mol. Endocrinol. 12: 1150-1160 [Abstract] [Full Text]
Kaibara, A., Moshyedi, A., Auffenberg, T., Abouhamze, A., Copeland, E. M. III, Kalra, S., Moldawer, L. L. (1998). Leptin produces anorexia and weight loss without inducing an acute phase response or protein wasting. Am. J. Physiol. Regul. Integr. Comp. Physiol. 274: R1518-R1525 [Abstract] [Full Text]
Hattori, K., Hirano, T., Miyajima, H., Yamakawa, N., Tateno, M., Oshimi, K., Kayagaki, N., Yagita, H., Okumura, K. (1998). Differential Effects of Anti-Fas Ligand and Anti-Tumor Necrosis Factor alpha �Antibodies on Acute Graft-Versus-Host Disease Pathologies. Blood 91: 4051-4055 [Abstract] [Full Text]
Warzocha, K., Ribeiro, P., Bienvenu, J., Roy, P., Charlot, C., Rigal, D., Coiffier, B., Salles, G. (1998). Genetic Polymorphisms in the Tumor Necrosis Factor Locus Influence Non-Hodgkin's Lymphoma Outcome. Blood 91: 3574-3581 [Abstract] [Full Text]
Ksontini, R., MacKay, S. L. D., Moldawer, L. L. (1998). Revisiting the Role of Tumor Necrosis Factor {alpha} and the Response to Surgical Injury and Inflammation. Arch Surg 133: 558-567 [Abstract] [Full Text]
Hattori, K., Hirano, T., Ushiyama, C., Miyajima, H., Yamakawa, N., Ebata, T., Wada, Y., Ikeda, S., Yoshino, K., Tateno, M., Oshimi, K., Kayagaki, N., Yagita, H., Okumura, K. (1997). A Metalloproteinase Inhibitor Prevents Lethal Acute Graft-Versus-Host Disease in Mice. Blood 90: 542-548 [Abstract] [Full Text]
Garcia-Ruiz, C., Colell, A., Mari, M., Morales, A., Fernandez-Checa, J. C. (1997). Direct Effect of Ceramide on the Mitochondrial Electron Transport Chain Leads to Generation of Reactive Oxygen Species. ROLE OF MITOCHONDRIAL GLUTATHIONE. J. Biol. Chem. 272: 11369-11377 [Abstract] [Full Text]
Hermansson, M., Wickelgren, R. B., Hammarqvist, F., Bjarnason, R., Wennstrom, I., Wernerman, J., Carlsson, B., Carlsson, L. M. S. (1997). Measurement of Human Growth Hormone Receptor Messenger Ribonucleic Acid by a Quantitative Polymerase Chain Reaction-Based Assay: Demonstration of Reduced Expression after Elective Surgery. J. Clin. Endocrinol. Metab. 82: 421-428 [Abstract] [Full Text]
Kuno, K., Kanada, N., Nakashima, E., Fujiki, F., Ichimura, F., Matsushima, K. (1997). Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene. J. Biol. Chem. 272: 556-562 [Abstract] [Full Text]
Sarraf, P., Frederich, R. C., Turner, E. M., Ma, G., Jaskowiak, N. T., Rivet, D. J. III, Flier, J. S., Lowell, B. B., Fraker, D. L., Alexander, H. R. (1997). Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia. J. Exp. Med. 185: 171-176 [Abstract] [Full Text]
Packer, M. (1995). Is Tumor Necrosis Factor an Important Neurohormonal Mechanism in Chronic Heart Failure?. Circulation 92: 1379-1382 [Full Text]
Kr�mer, B., Wiegmann, K., Kr�nke, M. (1995). Regulation of the Human TNF Promoter by the Transcription Factor Ets. J. Biol. Chem. 270: 6577-6583 [Abstract] [Full Text]
Cheng, J, Turksen, K, Yu, Q C, Schreiber, H, Teng, M, Fuchs, E (1992). Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.. Genes Dev. 6: 1444-1456 [Abstract]
Smith, C., Davis, T, Anderson, D, Solam, L, Beckmann, M., Jerzy, R, Dower, S., Cosman, D, Goodwin, R. (1990). A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248: 1019-1023 [Abstract]
Bai, J., Cederbaum, A. I. (2000). Overexpression of Catalase in the Mitochondrial or Cytosolic Compartment Increases Sensitivity of HepG2 Cells to Tumor Necrosis Factor-alpha -induced Apoptosis. J. Biol. Chem. 275: 19241-19249 [Abstract] [Full Text]
Lang, C. H., Frost, R. A., Nairn, A. C., MacLean, D. A., Vary, T. C. (2002). TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am. J. Physiol. Endocrinol. Metab. 282: E336-E347 [Abstract] [Full Text]